Atlantic Coastal Acquisition II (ACAB) Stock Price, News & Analysis
Company Description
Atlantic Coastal Acquisition II (NASDAQ: ACAB) is classified in the Biological Products, (no Disgnostic Substances) sector and carries a market capitalization of $84.4M, ranking #5,370 among all listed U.S. companies by market cap.
ACAB has declined 45.5% over the past year. Shares last traded at $11.00.
This page collects what Stock Titan holds for ACAB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Atlantic Coastal Acquisition II (ACAB) stock last closed at $11.00. Over the past 12 months, the stock has lost 45.5%. At a market capitalization of $84.4M, ACAB is classified as a micro-cap stock with approximately 8.0M shares outstanding.
ACAB Rankings
Latest News
Atlantic Coastal Acquisition II has 7 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all ACAB news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACAB Company Profile & Sector Positioning
Atlantic Coastal Acquisition II (ACAB) operates in the Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.